(Q34114555)

31 July 2017

1 reference

title

Primary phagocytic disorders of childhood (English)

1 reference

31 July 2017

Segal BH

1

1 reference

31 July 2017

Holland SM

series ordinal

2

1 reference

31 July 2017

publication date

1 December 2000

1 reference

Pediatric Clinics of North America

31 July 2017

published in

1 reference

31 July 2017

volume

47

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

1311-1338

1 reference

Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Urinary tract disorders in patients with chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Disseminated Mycobacterium flavescens in a probable case of chronic granulomatous disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Neutopaenia in a Cytomegalovirus (CMV) Infected WLBW Infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Gastrointestinal complications of chronic granulomatous disease: case report and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Impaired Microtubule Assembly and Polymorphonuclear Leucocyte Function in the Chediak-Higashi Syndrome Correctable by Ascorbic Acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Correction of Leukocyte Function in Chediak-Higashi Syndrome by Ascorbate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Autoimmune neutropenia associated with chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Leukocyte transfusions in chronic granulomatous disease: persistence of transfused leukocytes in sputum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Bone marrow transplantation in chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

O2- production by B lymphocytes lacking the respiratory burst oxidase subunit p47phox after transfection with an expression vector containing a p47phox cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Defective granulocyte chemotaxis in the Chediak-Higashi syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Chemotactic Factor Inactivation by the Myeloperoxidase-Hydrogen Peroxide-Halide System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Fungal infection in chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

7 January 2021

Studying X inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Cloxacillin Chemoprophylaxis in the Chediak-Higashi Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Cyclic hematopoiesis: the mechanism of cyclic neutropenia in grey collie dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Kinetics of transfused neutrophils in peripheral blood and BAL fluid of a patient with variant X-linked chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Neutrophil storage pool depletion in neonates with sepsis and neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Neutrophil specific granule deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

NIH conference. Recent advances in chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Interferon-gamma in the management of infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Genetic linkage of hyper-IgE syndrome to chromosome 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Chediak-Higashi gene in humans. I. Impairment of natural - killer function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Leukotriene B4 metabolism in neutrophils of patients with chronic granulomatous disease: phorbol myristate acetate decreases endogenous leukotriene B4 via NADPH oxidase-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Treatment of cyclic neutropenia with granulocyte colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Neutropenia in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Neutropenia and congenital cytomegalovirus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

The p47phox mouse knock-out model of chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

"Idiopathic neutropenia" in very low birthweight infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Marrow transplantation in chronic granulomatous disease: an update, with 6-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Bone marrow transplantation in chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Successful treatment of systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Invasive infection with Sarcinosporon inkin in a patient with chronic granulomatous disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

An in vivo animal model of gene therapy for leukocyte adhesion deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Prevalence of myeloperoxidase deficiency: population studies using Bayer-Technicon automated hematology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Autoimmune neutropenia of infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

The Role of Phagocytic Respiratory Burst in Host Defense Against Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Chronic granulomatous disease in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Selective defect in myeloid cell lactoferrin gene expression in neutrophil specific granule deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Chromobacterium violaceum infectious and chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Restitution of superoxide generation in autosomal cytochrome-negative chronic granulomatous disease (A22(0) CGD)-derived B lymphocyte cell lines by transfection with p22phax cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

The molecular basis of chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Incidence, severity, and prevention of infections in chronic granulomatous disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

A new immunodeficiency disorder in humans involving NK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Aspergillus nidulans Infection in Chronic Granulomatous Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Genetic, biochemical, and clinical features of chronic granulomatous disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Chronic bullous disease of childhood and a paecilomyces lung infection in chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Gene transfer to primary chronic granulomatous disease monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

In vitro molecular reconstitution of the respiratory burst in B lymphoblasts from p47-phox-deficient chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Testing for chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Pathophysiology and treatment of severe chronic neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Successful Treatment of Paecilomyces varioti Infection in a Patient with Chronic Granulomatous Disease and a Review of Paecilomyces Species Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Chronic granulomatous disease. Report on a national registry of 368 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Correction of Human Cyclic Neutropenia with Prednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

The urological manifestations of chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970273-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70273-X

1 reference

31 July 2017

1 reference